SYRS - Wall Street Estimates - Syros Pharmaceuticals, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.0786

-45.1 %

$ 2.11 M

Market Cap

-0.03

P/E

Price Target Average

13894.91%

Revenue Forecast Estimate

--44.85%

EBIT Estimate

76.53%

Net Income Estimate

24.98%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Syros Pharmaceuticals, Inc.

Wall Street analysts predict an average 1-year price target for SYRS of $11 , with forecasts ranging from a low of $5 to a high of $15 .

SYRS Lowest Price Target Wall Street Target

5 USD 6261.32%

SYRS Average Price Target Wall Street Target

11 USD 13894.91%

SYRS Highest Price Target Wall Street Target

15 USD 18983.97%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free